Julia H. Rowland and Tom Smith receive NCCS Ellen L. Stovall Award

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

Julia H. Rowland, member of the National Coalition for Cancer Survivorship Board of Directors and former director of NCI’s Office of Cancer Survivorship, and Thomas J. Smith, director of palliative medicine for Johns Hopkins Medicine, received the 2020 Ellen L. Stovall Award for Innovation in Patient-Centered Cancer Care, presented by The National Coalition for Cancer Survivorship.

Rowland and Smith received the award Nov. 18 at the NCCS virtual awards reception.

The award is named for former NCCS CEO Ellen Stovall, who died in 2016 due to long-term complications from three bouts of cancer.

Rowland is a long-time clinician, researcher, and teacher in the area of psychosocial aspects of cancer. She has worked with and conducted competitively funded research among both pediatric and adult cancer survivors and published broadly in psycho-oncology.

She was recruited to NCI to become the first, full-time director of the Office of Cancer Survivorship. After 18 years in this role, Rowland retired from service at the NCI in September 2017 and assumed the role of senior strategic advisor at Smith Center for Healing and the Arts, a small non-profit organization that provides integrative support services to cancer patients and their families.

Smith is a professor of oncology at the Johns Hopkins University School of Medicine and the Harry J. Duffey Family Professor of Palliative Care.

He is a medical oncologist and a palliative care specialist with a lifelong interest in better symptom management, communication, and improving access to high quality affordable care.

Smith began Johns Hopkins’ hospital-wide palliative care consult service as well as an inpatient unit. He is also a prostate cancer survivor, experiencing first-hand surgery, recurrence, salvage radiation therapy and androgen deprivation therapy with many significant side effects.

Delegate Eleanor Holmes Norton (D-DC) presented the award to her constituent, Julia H. Rowland, and Sen. Chris Van Hollen (D-MD) presented the award to his constituent, Thomas J. Smith.

Table of Contents

YOU MAY BE INTERESTED IN

When our hematological malignancy testing pilot project began in Eldoret, Kenya, there seemed to be a mismatch in relation to progress in healthcare. The region, like much of sub-Saharan Africa, had been focusing on combatting infectious diseases such as HIV and malaria—which was much-needed—yet cancer care was under-resourced. 
Artificial intelligence is rapidly transforming biomedical research and healthcare. Large language models, foundation models, and AI agents are increasingly being deployed to assist with data interpretation, literature review, clinical decision support, and translational research. 
In modern oncology, important insights from clinical trials often emerge years after initial publication. As new therapies extend survival and transition more patients into long-term remissions, clinicians and researchers are increasingly looking beyond initial response rates to understand durability, long-term safety, and even the possibility of a cure. 

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login